VTT Makes New Investments in Digital Health

VTT is launching new research activities in the area of digital health as part of the growing wellbeing and health technology ecosystem in Kuopio. The new initiative aims to create state-of-the-art research based especially on the utilisation of health data, generate new digital health innovations and establish global health technology business in Finland and the Kuopio region.

Health technology is already a strong growth and export sector in Finland, but new technologies based on health data have enormous potential for commercialisation. In Kuopio, the universities of the area, the strong role of the business community and the active involvement of the city have created an ecosystem that VTT will strengthen in the future, especially with its expertise in data analytics and digital solutions. As part of the ecosystem, VTT strives to improve the business conditions of the region’s health technology companies and to increasingly direct industry expertise from research to product development.

Digital tools to support decision-making and guide the use of health care resources

The growing cost pressures on health care create a need for new technology-based solutions, including in preventive health care, early diagnosis, and choosing the care path that provides the best benefit. These will be some of the focus areas in Kuopio.

"Finland's unique health data compiled in national registers enables the development of data-based solutions to solve global and public health challenges. However, utilising the data in health care decision-making requires determined work to develop new digital tools, and VTT will be investing heavily in this going forward," comments VTT’s President & CEO Antti Vasara.

VTT's long-standing and multidisciplinary experience in, for example, mining big health data and developing machine learning and artificial intelligence solutions will further strengthen the Kuopio Health ecosystem and improve the international competitiveness of the region’s companies.

"For example, there is an acute need for the early diagnosis of brain disorders, such as progressive memory disease and depression, and for improving the efficiency of care paths, which we will be better able to address in the coming years through tools that combine extensive health data," says Research Professor Markus Forsberg from VTT’s Kuopio office.

Kuopio as a catalyst in health data projects

VTT has a long history of working in the area of digital health in Espoo, Tampere, Oulu and Kuopio. There have been operations in Kuopio since 2005. In the future, the office will focus especially on research and innovation projects utilising extensive health data.

DigiTerveSavo 1 was launched in Kuopio in December 2019 as the first new digital health cooperation project, with funding from the Regional Council of Pohjois-Savo amounting to EUR 761,000. The project will develop a concept for data-driven tools to support early diagnosis and choice of care path that can be used to enhance the use of health care resources and to promote citizens’ health. In addition, VTT is participating in improving the usability of health data in the Kuopio region together with other operators.

A cooperation seminar focusing on digital health organised today by VTT and the City of Kuopio will be attended by Chair of the Social Affairs and Health Committee, Member of Parliament Anu Vehviläinen, VTT's President & CEO Antti Vasara, Mayor of Kuopio Jarmo Pirhonen as well as other top experts in the field to discuss the opportunities in the industry and region.

About VTT

VTT is a visionary research, development and innovation partner. We drive sustainable growth and tackle the biggest global challenges of our time, and turn them into growth opportunities. We go beyond the obvious to help the society and companies to grow through technological innovations. We have over 75 years of experience of top-level research and science-based results.

VTT is at the sweet spot where innovation and business come together.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...